Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

AI-powered neural gesture technology enables personalized, intuitive interactions for the AI and XR eraYokneam Illit, ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies based on DNA-damage response ...

In the latest iteration of See Your Risks, Bayer takes aim at denial among millennials and Gen Xers when it comes to heart ...

Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) grew attributable proven and probable gold mineral reserves by 17.4 million ...

Find Sam Altman On Artificial Intelligence Latest News, Videos & Pictures on Sam Altman On Artificial Intelligence and see latest updates, news, information from NDTV.COM. Explore more on Sam Altman ...

Baron Durable Advantage Fund advanced during the fourth quarter of 2024, outpacing its benchmark, the S&P 500 Index.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) grew attributable proven and probable gold mineral reserves by 17.4 million ...

Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...